Every Form 4 that Evolv Technologies Holdings, Inc. (EVLV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow EVLV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EVLV filings page.
At Evolv Technologies Holdings, Inc. (EVLV), director Neil Glat's unvested founder shares were automatically forfeited and cancelled on July 16, 2026: 17,500 shares and 15,091 shares, each for no consideration because applicable vesting conditions were not satisfied.
Evolv Technologies Holdings, Inc. (EVLV) director Kevin M. Charlton reported that 67,500 unvested founder shares were automatically forfeited and cancelled for no consideration on July 16, 2026, because applicable vesting conditions were not satisfied. Afterward, he held 291,510 Class A common shares directly and 44,081 shares indirectly through an IRA.
Evolv Technologies Holdings, Inc. (EVLV) director Richard A. Shapiro reported open-market purchases of a total of 32,600 shares of Class A Common Stock on September 4, 2026. He bought 13,500 shares directly at a weighted average price of $4.96 per share, increasing his direct holdings to 93,065 shares. Additional purchases were made through indirect accounts: 6,500 shares held by a trust over which he has voting and dispositive power (now 29,000 shares), 9,000 shares held by his spouse (now 39,000 shares), and 3,600 shares held in his spouse’s retirement plan (now 20,000 shares). No Rule 10b5-1 trading plan is reported.
Evolv Technologies Holdings, Inc. (EVLV) director Michael Ellenbogen reported an option exercise-and-sale transaction. On August 17, 2026 he exercised 80,752 stock options at an exercise price of $0.24 per share, acquiring an equal number of Class A common shares, then sold 80,752 shares of Class A common stock at a $5.59 weighted average price in open-market or private transactions. After the option exercise, he held 816,262 options directly, and an additional 151,135 shares are held indirectly through the Family Horizon Trust. The sales were effected under a Rule 10b5-1 trading plan entered into on June 12, 2025.
Evolv Technologies Holdings, Inc. (EVLV) director Neil Glat purchased 8,500 shares of Class A Common Stock on August 14, 2026 at $5.74 per share in an open-market or private transaction. Following this transaction, he holds 252,100 shares with direct ownership.
Evolv Technologies Holdings, Inc. (EVLV) director Henrik Kuhl reported an open-market purchase of 15,000 shares of Class A Common Stock on 2026-08-14 at a weighted average price of $5.73 per share. These shares are held indirectly by a trust for which he is a co-trustee and beneficiary. Following the transactions reported, he also holds 9,291 shares directly.
Michael Ellenbogen, a director of Evolv Technologies Holdings, Inc., exercised stock options for 80,745 shares of Class A Common Stock at $0.24 per share and on the same date sold 80,745 shares at a weighted-average price of $5.94 under a Rule 10b5-1 trading plan. Following these transactions, he holds 2,083,961 shares directly, 151,135 shares indirectly through the Family Horizon Trust, and 897,014 stock options expiring on September 13, 2027.
Evolv Technologies Holdings director David Mounts Gonzales exercised restricted stock units that vested on June 17, 2026, converting them into 27,050 shares of Class A common stock. These RSUs represented a right to receive one share each and carried no expiration date.
After this compensation-related conversion, Gonzales directly holds 201,789 shares of Evolv Class A common stock. The filing does not show any open-market purchases or sales, only the exercise of equity awards previously granted to him.
Evolv Technologies Holdings, Inc. director Mark J. Sullivan exercised restricted stock units into common shares. On June 17, 2026, 27,050 RSUs vested in full and were converted into 27,050 shares of Class A common stock at no exercise price. Following this equity award vesting and conversion, he holds 242,628 Class A shares directly, with no same-day sale reported.
Evolv Technologies Holdings director Henrik Kuhl reported routine equity compensation activity. On June 18, 2026, he received a grant of 28,318 Restricted Stock Units, each representing one share of Class A common stock. These RSUs vest in full at the earlier of June 18, 2027 or the day immediately before the next annual meeting.
On June 17, 2026, 9,291 RSUs vested in full and were exercised into 9,291 shares of Class A common stock at no cash exercise price. Following these transactions, he directly holds 9,291 shares of Class A common stock from this exercise, along with the new 28,318-unit RSU award subject to future vesting.
Evolv Technologies Holdings director Kevin M. Charlton reported equity compensation and related share activity. He received a grant of 28,318 Restricted Stock Units (RSUs) on Class A common stock that will vest in full at the earlier of June 18, 2027 or the day immediately before the company’s next annual meeting. On June 17, 2026, a prior award of 27,050 RSUs vested in full, and these units were converted into the same number of Class A common shares, increasing his direct holdings to 359,010 shares. He also reports 44,081 Class A common shares held indirectly through an IRA.
Evolv Technologies Holdings director Richard A. Shapiro reported equity compensation activity in the form of restricted stock units (RSUs) and common stock. He received a grant of 28,318 RSUs, each representing a contingent right to one share of Class A common stock. These RSUs will vest in full at the earlier of June 18, 2027 or the day immediately preceding the company’s next annual meeting date.
Separately, 27,050 RSUs vested in full on June 17, 2026 and were exercised into 27,050 shares of Class A common stock, after which he held 79,565 shares directly. The filing also shows indirect holdings of 16,400 shares held by his spouse in a retirement plan, 22,500 shares held by a trust for which he has voting and dispositive power over the share-based assets, and 30,000 shares held by his spouse.
Evolv Technologies Holdings director Kimberly H. Sheehy reported equity compensation activity, not open-market trading. On June 18, 2026, she received a grant of 28,318 Restricted Stock Units, each representing a contingent right to one share of Class A common stock.
The new RSUs will vest in full at the earlier of June 18, 2027 or the day immediately preceding the issuer's next annual meeting date. On June 17, 2026, 27,050 RSUs vested and were exercised into 27,050 shares of Class A common stock. Following these transactions, Sheehy directly holds 170,085 common shares.
Evolv Technologies Holdings director Neil Glat reported equity compensation activity and an option-equivalent exercise. He received a grant of 28,318 Restricted Stock Units, each representing one share of Class A common stock. These RSUs will vest in full at the earlier of June 18, 2027 or the day immediately preceding the company’s next annual meeting date.
Separately, RSUs covering 27,050 shares vested in full on June 17, 2026 and were exercised into 27,050 shares of Class A common stock. Following these transactions, Glat directly holds 243,600 shares of Class A common stock and 28,318 outstanding RSUs.
Ellenbogen Michael reported acquisition or exercise transactions in this Form 4 filing.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported an award of 28,318 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the company’s Class A common stock and has no expiration date.
The 28,318 RSUs will vest in full on the earlier of June 18, 2027 or the day immediately before the company’s next annual meeting date. Following this grant, Ellenbogen holds 28,318 RSUs directly, reflecting a compensation-related equity award rather than an open-market share purchase.
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold shares on the same day. He exercised options to acquire 80,745 shares of Class A Common Stock at an exercise price of $0.24 per share, then sold 80,745 shares at a weighted average price of $6.21 per share. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025. Following these transactions, he holds 2,083,961 shares of Class A Common Stock directly and 151,135 shares indirectly through the Family Horizon Trust, and retains 977,759 stock options.
Evolv Technologies Holdings, Inc. Chief Revenue Officer Robert E. Marshall exercised 136,363 Restricted Stock Units (RSUs) into shares of Class A common stock and reported a related sale. He sold 62,067 shares at a weighted average price of $6.85 per share, with the sale effected solely to cover withholding taxes tied to RSU vesting. After these transactions, he holds 81,296 shares of Class A common stock directly and 272,727 RSUs, which vest in three equal annual installments starting on March 1, 2026.
Evolv Technologies Holdings director Michael Ellenbogen reported an exercise-and-sell transaction in Class A Common Stock. He exercised stock options for 80,745 shares at $0.24 per share and sold 80,745 shares at a weighted average price of $5.63 per share under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025, with sale prices ranging from $5.53 to $5.77. Following these transactions, he directly owns 2,083,961 shares and indirectly holds 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings, Inc. Chief Financial Officer George C. Kutsor reported routine equity compensation activity. He exercised restricted stock units to acquire 138,888 shares of Class A common stock, then sold 51,448 shares at a weighted average price of $7.27 per share.
According to the filing, the sale was made solely to cover withholding taxes tied to RSU vesting, rather than as a discretionary stock sale. After these transactions, he directly holds 87,440 shares of Class A common stock and 277,778 RSUs, which vest in three equal annual tranches, each RSU representing a right to receive one share.
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold shares in a routine, pre-planned transaction. He exercised 80,745 stock options at an exercise price of $0.24 per share, receiving the same number of Class A Common shares.
On the same day, he sold 80,745 Class A Common shares at a weighted average price of $6.32 per share under a Rule 10b5-1 trading plan. After these transactions, he directly owned 2,083,961 Class A Common shares and indirectly held 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported an open-market sale of 91,771 shares of Class A common stock at a weighted average price of $5.10 per share. The sale was made under a Rule 10b5-1 trading plan entered into on June 12, 2025.
The footnotes state that individual trades occurred between $5.04 and $5.17. After this sale, Ellenbogen directly owned 2,083,961 shares, and separately had 151,135 shares held indirectly through the Family Horizon Trust as a reported holding.
Kedzierski John reported acquisition or exercise transactions in this Form 4 filing.
Evolv Technologies Holdings President & CEO John Kedzierski received a grant of 373,831 Restricted Stock Units, each representing one share of Class A common stock at no cash cost. The RSUs vest in three equal annual installments beginning on March 2, 2027, and have no expiration date.
Marshall Robert E reported acquisition or exercise transactions in this Form 4 filing.
Evolv Technologies Holdings, Inc. reported that Chief Revenue Officer Robert E. Marshall received a grant of 186,915 Restricted Stock Units on March 2, 2026. Each RSU represents a contingent right to receive one share of Class A common stock. The award vests in three equal annual installments starting on March 2, 2027.
Kutsor George C reported acquisition or exercise transactions in this Form 4 filing.
Evolv Technologies Holdings, Inc. reported that Chief Financial Officer George C. Kutsor received an equity award of 186,915 Restricted Stock Units (RSUs) on March 2, 2026. Each RSU represents a contingent right to receive one share of Class A common stock and has no expiration date.
The RSUs were granted at no cash cost and will vest in three equal annual installments starting on March 2, 2027, tying the CFO’s compensation to the company’s long-term performance and continued service.
Evolv Technologies Holdings director Michael Ellenbogen reported both RSU vesting and a small share sale. He sold 82,913 shares of Class A common stock in an open-market transaction at a weighted average price of $5.19 per share, with individual trades ranging from $5.19 to $5.29, solely to cover withholding taxes owed on vesting RSUs.
On the prior day, he exercised and converted 66,787, 57,392 and 50,505 Restricted Stock Units into the same number of Class A shares at no cost, reflecting scheduled vesting of RSU awards. Each RSU represents one share and has no expiration, vesting in three equal annual installments beginning on March 1 of 2024, 2025 and 2026, respectively.
After these transactions, Ellenbogen directly owns 2,175,732 shares of Evolv Class A common stock and also reports indirect ownership of 151,135 shares held by the Family Horizon Trust.
Evolv Technologies Holdings founder and Chief Growth Officer Anil Chitkara reported multiple equity transactions. He received a grant of 46,728 Restricted Stock Units (RSUs) on March 2, 2026, which vest in three equal annual installments commencing on March 2, 2027.
On March 1, 2026, he exercised several RSU awards, converting 53,430, 45,913 and 37,878 RSUs into an equal number of Class A common shares at no cost. He then sold 63,670 Class A shares at a weighted average price of $5.19 per share, in transactions ranging from $5.19 to $5.30.
According to the disclosure, this sale was effected solely to cover withholding taxes related to RSU vesting. After the transactions, he directly owned 1,348,651 Class A common shares and continued to hold additional unvested RSUs subject to multi-year vesting schedules.
Evolv Technologies Holdings, Inc. reported that director Henrik Kuhl acquired 9,291 restricted stock units (RSUs) as a grant. Each RSU represents a contingent right to receive one share of Class A common stock and has no expiration date.
The RSUs will vest in full at the earlier of June 20, 2026 or the day immediately before the company’s next annual meeting. Following this grant, Kuhl holds a total of 9,291 RSUs directly.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen exercised a stock option for 80,745 shares on February 17, 2026, converting options at an exercise price of $0.24 per share into Class A common stock. The same day, he sold 80,745 Class A shares in an open-market transaction at a weighted average price of $5.47 per share, with individual trades ranging from $5.39 to $5.65, under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025. Following these transactions, he directly owned 2,083,961 Class A shares and indirectly held 151,135 shares through Family Horizon Trust.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported option exercises and share sales in Class A Common Stock. On January 16, 2026, he exercised a stock option for 80,745 shares at an exercise price of $0.24 per share and acquired the same number of shares. That same day, he sold 80,745 shares at a weighted average price of $6.20 per share, with individual sale prices ranging from $6.13 to $6.37, under a pre-existing Rule 10b5-1 trading plan entered into on June 12, 2025.
After these transactions, Ellenbogen directly beneficially owned 2,083,961 shares of Class A Common Stock and held 1,300,739 stock options. He also indirectly held 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings, Inc. reported that director Mark J. Sullivan received a grant of 3,731 Restricted Stock Units (RSUs) on January 2, 2026. Each RSU represents a contingent right to receive one share of the company’s Class A common stock at no purchase price, and the RSUs have no expiration date.
The filing states that these 3,731 RSUs will vest in full on December 31, 2026, after which they can settle into an equal number of Class A common shares, assuming vesting conditions are met. Following this award, Sullivan beneficially owns 3,731 RSUs directly.
Evolv Technologies Holdings, Inc. (EVLV) reported a new equity grant to one of its directors. Director Michael Ellenbogen was awarded 3,731 Restricted Stock Units (RSUs) on January 2, 2026, at a price of $0 per unit, and now holds 3,731 derivative securities directly following this transaction.
Each RSU represents a contingent right to receive one share of Evolv’s Class A common stock and has no expiration date. According to the disclosure, all 3,731 RSUs will vest in full on December 31, 2026, meaning Ellenbogen will receive an equal number of Class A shares if the vesting conditions are satisfied.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported insider transactions in Class A Common Stock. On December 15, 2025 he exercised stock options for 80,745 shares at an exercise price of $0.24 per share and on the same day sold 80,745 shares at a weighted average price of $6.91 per share under a Rule 10b5-1 trading plan entered into on June 12, 2025. The sales occurred in multiple trades at prices ranging from $6.75 to $7.20.
After these transactions he held 2,083,961 shares directly, 151,135 shares indirectly through the Family Horizon Trust, and 1,381,484 stock options.
Evolv Technologies Holdings, Inc. (EVLV) executive Robert Marshall, the company’s Chief Revenue Officer, reported an open-market purchase of Class A common stock. On 11/25/2025, he acquired 7,000 shares at a price of $6.06 per share, reported with transaction code "P" for a purchase. Following this transaction, he beneficially owns 7,000 Class A shares, held directly.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by its President & CEO and Director, John Kedzierski. On 11/21/2025, the reporting person bought 8,000 shares of Class A common stock in an open market transaction at a weighted average price of $5.91 per share. The filing notes the shares were acquired in multiple trades at prices ranging from $5.89 to $5.91, and the reporting person has offered to provide full trade details upon request. After this transaction, the insider directly holds 8,000 shares.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by a director. On 11/21/2025, the reporting person acquired 15,000 shares of Class A common stock in an open market purchase at a price of $5.6797 per share, through an IRA account. Following this transaction, the director beneficially owns 44,081 shares indirectly through the IRA and 331,960 shares directly. The filing is made by a single reporting person in the capacity of director, highlighting continued personal equity ownership in the company.
Evolv Technologies Holdings, Inc. (EVLV) director Richard Shapiro reported multiple open-market purchases of Class A common stock on 11/20/2025. He bought 30,000 shares directly at a weighted average price of about $6.00, with individual trades ranging from $5.97 to $6.02. He also acquired 7,500 shares held by a trust over which he has voting and dispositive power and 8,800 shares held by his spouse in a retirement plan, both at weighted average prices around $6.02. After these transactions, he directly owned 52,515 shares, while indirect holdings included shares in the trust and accounts related to his spouse.
Evolv Technologies Holdings, Inc. (EVLV) director reported an option exercise and share sale. On 11/17/2025, the reporting person exercised stock options to acquire 80,745 shares of Class A common stock at $0.24 per share and then sold 80,745 shares at a weighted average price of $5.8, with individual trades ranging from $5.69 to $5.99. These transactions were made under a Rule 10b5-1 trading plan entered into on June 12, 2025. After the transactions, the reporting person directly beneficially owned 2,083,961 shares, with an additional 151,135 shares held indirectly through the Family Horizon Trust, and continued to hold 1,462,229 stock options.
Evolv Technologies Holdings (EVLV): Founder & Chief Growth Officer Anil Chitkara reported option exercises and open‑market sales. On 10/24/2025 and 10/27/2025, he exercised a total of 360,000 stock options at $0.24 and $0.42 per share and sold 360,000 Class A shares at a weighted average price of $8.20. The 10/24 sales occurred within $8.03–$8.34, and the 10/27 sale within $8.13–$8.30.
Following these transactions, he beneficially owned 1,275,100 shares directly. Option footnotes state one grant vested 25% on January 31, 2018 with 36 monthly installments thereafter, and another vested 25% on January 1, 2022 with 36 monthly installments thereafter.